Stock Price
74.26
Daily Change
-0.16 -0.22%
Monthly
7.81%
Yearly
0.20%
Q2 Forecast
72.77

Solventum Corp reported $561M in Cash and Equivalent for its fiscal quarter ending in March of 2026.





Cash And Equivalent Change Date
Abbott USD 6.8B 1.72B Mar/2026
Align Technology USD 1.06B 35.07M Mar/2026
Baxter International USD 2.02B 51M Mar/2026
Becton, Dickinson and Co. USD 813M 73M Mar/2026
Cencora USD 1.75B 2.6B Dec/2025
Dexcom USD 1.12B 200.5M Mar/2026
Insulet USD 480.4M 235.7M Mar/2026
Solventum Corp USD 561M 317M Mar/2026
West Pharmaceutical Services USD 521.4M 269.9M Mar/2026
Zimmer Biomet Holdings USD 424.2M 167.7M Mar/2026